Research funder · United States
Michael J. Fox Foundation for Parkinson's Research
Non-profit organization in the USA
- Grants since 2016
- 1 275
- Awarded, last 5 years (where amounts are published)
- —
- Funded works, last 5 years
- 3 085
- Funded works, all time
- 6 716
Grants
2026 · research · ASAP CRN Discovery Fellowship 2025
Cryo-ET and Lipidomics of Lysosome Damage in Familial and Sporadic Parkinson’s Disease
Eric Herrmann
2026 · research · Research Grant
Parallelized Digital Seed Amplification Assay for PD Biomarker Development
Tuomas Knowles · University of Cambridge
2026 · research · Spring 2025 RFA: Molecular MRI Biomarker Program
MR Imaging of Immunomodulation in Parkinson’s Disease
Eric M. Gale · Massachusetts General Hospital
2026 · research · ASAP CRN Discovery Fellowship 2025
How Cell Communication Problems May Contribute to Parkinson’s Disease
Prosenjit Pal
2026 · research · Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program
ADAPT-GAIT: Adaptive deep brain stimulation controlled by neural biomarkers of gait to alleviate locomotor deficits in people with advanced Parkinson's disease
Eduardo Martin Moraud · University of Lausanne
2026 · research · ASAP CRN Discovery Fellowship 2025
Exploring How Mutations in the LRRK2 Gene Change mRNA and Protein Selection and How This Can Be Used for Diagnosis and Treatment of Parkinson’s Disease
Jonathan Brenton
2026 · research · Research Grant
Disease Modeling for Neuronal Alpha-synuclein Diseases
Tanya Simuni · Northwestern University
2026 · research · Spring 2025 RFA: Molecular MRI Biomarker Program
Mapping Mitochondrial Dysfunction in Parkinson’s Disease Using 15N-Magnetic Resonance of Nicotinamide Metabolism (MiND15)
Jannik Prasuhn · University of Lübeck
2026 · research · ASAP CRN 2025 RFA Scientific Track
Mitochondrial Surface as a Neuroprotective Signal Integrator in PD
Miratul Muqit · University of Dundee
2026 · research · ASAP CRN 2025 RFA Scientific Track
Ventral Tegmental Area Dopamine Neuron Subtype-Specific Roles in Parkinson's Disease-Related Cognitive Symptoms
David H. Root · University of Colorado Boulder
2026 · research · Research Grant
Multiscale Measurement of O-GlcNAc Changes in Parkinson’s Disease
Matthew Pratt · University of Southern California
2026 · research · ASAP CRN 2025 RFA Scientific Track
Investigating the Role of Immune Cell Exhaustion (ICE) and Biological Immune Aging (BIA) in PD Risk and PD Heterogeneity
Maria De Lourdes (Malú) Gámez Tansey · Indiana University School of Medicine
2026 · research · ASAP CRN Discovery Fellowship 2025
Recapitulating Subtype-Specific Cell-Autonomous Human Dopaminergic Vulnerability in Parkinson’s Disease
Janko Kajtez
2026 · research · ASAP CRN 2025 RFA Scientific Track
Environmental & Genetic Determinants of Parkinson’s Disease Progression
Jeff Bronstein · University of California, Los Angeles
2026 · research · Summer 2025 RFP: Accelerating Biological Understanding and Translational Approaches for PD Program - Biomarkers
Dried Blood Spot Based Biomarkers
Roy Alcalay · Columbia University
2026 · research · Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program
Sensing-Enabled Directional Deep Brain Stimulation of the Cuneiform Nucleus for Levodopa-Resistant Freezing of Gait in Parkinson’s Disease
Iahn Cajigas · University of Pennsylvania
2026 · research · ASAP CRN Discovery Fellowship 2025
Untangling PINK1–Tau Crosstalk and Co-Morbidity Mechanisms in Parkinson’s Disease
Odetta Antico
2026 · research · ASAP CRN Discovery Fellowship 2025
How the Spatiotemporal Dynamics of Dopamine Transmission Shift in Parkinson’s Disease to Support Motor Function
Matthew Mcgregor
2026 · research · ASAP CRN Discovery Fellowship 2025
Dynamic Regulatory Role of Transposable Elements Through Human Ageing and Parkinson’s Disease
Raquel Garza Gómez
2026 · research · ASAP CRN 2025 RFA Scientific Track
Decoding Alpha-Synuclein Conformational Diversity to Enable Advanced Predictive Amplification Assays
Andrew West · Duke University
2026 · research · ASAP CRN 2025 RFA Scientific Track
Defining the Neural Mechanisms Underlying Heterogeneity in Sleep and Circadian Rhythm Disturbances in Parkinson’s Disease
Andrew Sharott · University of Oxford
2026 · research · Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program
PWR-PD (“Power-PD”): Personalized Wearable-based Rehabilitation for Parkinson’s Disease
Giovanna Lopane · Istituto delle Scienze Neurologiche di Bologna
2026 · research · Research Grant
Discovery of Selective PET Imaging Agents for Tauopathies
Neil Vasdev · Centre for Addiction and Mental Health
2026 · research · Research Grant
Differential Expression of Aging-related Genes and Co-expression with SNCA and MAPT in Parkinson’s Disease Patients and Healthy Controls
Jackson G. Schumacher · Massachusetts General Hospital
2026 · research · Research Grant
Biofluid Markers in Multiple System Atrophy
Un Jung Kang · New York University
2026 · research · Spring 2025 RFP: Accelerating Biological Understanding and Therapeutic Translation for PD-Biomarkers
Oxylipin Profiles in LRRK2 Mutation Carriers: Biomarkers for Parkinson’s Disease
Sayuri Miyamoto · Universidade de São Paulo
2026 · research · T2T Validation - Endolysosomal Targets
Toward an Atlas of Endolysosomal System Dysfunction with PD-associated Channels/Transporters
J. Wade Harper · Harvard University
2026 · research · Research Grant
α-Synuclein Pathology Beyond Lewy-related Pathology: α-synuclein Oligomers and Seeding Activity in LRRK2-related Parkinson’s Disease
Hiroaki Sekiya · Mayo Clinic
2026 · research · ASAP CRN 2025 RFA Scientific Track
Seeded Aggregation of Alpha-Synuclein
Michel Goedert · Medical Research Council
2026 · research · Research Grant
Discovery of Selective PET Imaging Agents for Alpha-Synuclein
Neil Vasdev · Centre for Addiction and Mental Health
2026 · research · Research Grant
Neuroimmune Assay Workstream Validation
Etty (Tika) N. Benveniste · University of Alabama at Birmingham
2026 · research · Spring 2025 RFP: Accelerating Biological Understanding and Therapeutic Translation for PD- Biology
Deciphering Intracellular Pathways Altered by LRRK2 Kinase Activity and Phospho-RAB Effector Function
Sabine Hilfiker · Rutgers, The State University of New Jersey
2026 · research · ASAP CRN Discovery Fellowship 2025
Parsing the Diverse Neuromodulation of Vulnerable Versus Resistant Dopamine Axons According to Distinct Molecular Subtype
Kathryn Todd
2026 · research · Parkinson’s Disease Therapeutics Pipeline Program - Pre-Clinical
Preclinical Efficacy Studies for CU-13001, a 15-Lipoxygenase Inhibitor for the Treatment of Parkinson’s Disease
William Dvořák Shrader · Acurex Therapeutics Corporation
2026 · research · ASAP CRN Discovery Fellowship 2025
Can Alpha Synuclein Move Between Neurons?
Caroline Haikal
2026 · research · ASAP CRN 2025 RFA Scientific Track
Defining Functional Heterogeneity Within the Subthalamic Area and Its Relevance for Psychiatric Symptoms of PD
Åsa Mackenzie · Lund University
2026 · research · Summer 2023 RFP: Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program - Biology
Characterization of Constrained Peptides Targeting LRRK2 and Downstream Signaling
Eileen J. Kennedy · University of North Carolina at Chapel Hill
2026 · research · Research Grant
From Functional Maps to Clinical Outcomes: Interpreting GBA1 Variant Effects in Parkinson's Disease
Grzegorz Kudla · University of Edinburgh
2026 · research · Research Grant
Deep Mutational Scanning of TMEM175
Grzegorz Kudla · University of Edinburgh
2026 · research · Research Grant
Parkinson’s Clinical Cohorts Collaborative (PC3)
Alastair Noyce · Queen Mary University of London
